These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10338477)

  • 1. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.
    Bakaletz LO; Kennedy BJ; Novotny LA; Duquesne G; Cohen J; Lobet Y
    Infect Immun; 1999 Jun; 67(6):2746-62. PubMed ID: 10338477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.
    Kennedy BJ; Novotny LA; Jurcisek JA; Lobet Y; Bakaletz LO
    Infect Immun; 2000 May; 68(5):2756-65. PubMed ID: 10768970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx.
    Kyd JM; Cripps AW; Novotny LA; Bakaletz LO
    Infect Immun; 2003 Aug; 71(8):4691-9. PubMed ID: 12874350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide and recombinant antigens for protection against bacterial middle ear infection.
    Bakaletz LO
    Vaccine; 2001 Mar; 19(17-19):2323-8. PubMed ID: 11257356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.
    Poolman JT; Bakaletz L; Cripps A; Denoel PA; Forsgren A; Kyd J; Lobet Y
    Vaccine; 2000 Dec; 19 Suppl 1():S108-15. PubMed ID: 11163473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
    Winter LE; Barenkamp SJ
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla.
    Bakaletz LO; Leake ER; Billy JM; Kaumaya PT
    Vaccine; 1997 Jun; 15(9):955-61. PubMed ID: 9261941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential uptake and processing of a Haemophilus influenzae P5-derived immunogen by chinchilla dendritic cells.
    Novotny LA; Partida-Sánchez S; Munson RS; Bakaletz LO
    Infect Immun; 2008 Mar; 76(3):967-77. PubMed ID: 18160476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A.
    Sirakova T; Kolattukudy PE; Murwin D; Billy J; Leake E; Lim D; DeMaria T; Bakaletz L
    Infect Immun; 1994 May; 62(5):2002-20. PubMed ID: 7909539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.
    DeMaria TF; Murwin DM; Leake ER
    Infect Immun; 1996 Dec; 64(12):5187-92. PubMed ID: 8945564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model.
    Green BA; Vazquez ME; Zlotnick GW; Quigley-Reape G; Swarts JD; Green I; Cowell JL; Bluestone CD; Doyle WJ
    Infect Immun; 1993 May; 61(5):1950-7. PubMed ID: 8478084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Whitby PW; Morton DJ; Mussa HJ; Mirea L; Stull TL
    Vaccine; 2020 Mar; 38(14):2960-2970. PubMed ID: 32111525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas.
    Barenkamp SJ
    Infect Immun; 1996 Apr; 64(4):1246-51. PubMed ID: 8606086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models.
    Hong W; Peng D; Rivera M; Gu XX
    Microbes Infect; 2010 Jan; 12(1):11-8. PubMed ID: 19782149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.
    Novotny LA; Jurcisek JA; Pichichero ME; Bakaletz LO
    Infect Immun; 2000 Apr; 68(4):2119-28. PubMed ID: 10722609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.
    Novotny LA; Jurcisek JA; Godfroid F; Poolman JT; Denoël PA; Bakaletz LO
    Vaccine; 2006 May; 24(22):4804-11. PubMed ID: 16616975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM; Becker PD; Guzmán CA; Grinstein S
    J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.
    Novotny LA; Clements JD; Bakaletz LO
    Mucosal Immunol; 2011 Jul; 4(4):456-67. PubMed ID: 21326197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Protein E-PilA Fusion Protein Shows Vaccine Potential against Nontypeable Haemophilus influenzae in Mice and Chinchillas.
    Ysebaert C; Denoël P; Weynants V; Bakaletz LO; Novotny LA; Godfroid F; Hermand P
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.